Twist Bioscience Corporation (TWST) Debt / Equity
- 2020-12-31: Debt/Equity Ratio 0.01.
- 2020-09-30: Debt/Equity Ratio 0.01.
- 2020-06-30: Debt/Equity Ratio 0.02.
- 2020-03-31: Debt/Equity Ratio 0.02.
Complete source-backed debt/equity ratio history.
- Available history
- 2018-09-30 to 2020-12-31
- Data captured
Historical Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2020-12-31 | 0.01 |
| 2020-09-30 | 0.01 |
| 2020-06-30 | 0.02 |
| 2020-03-31 | 0.02 |
| 2019-12-31 | 0.07 |
| 2019-09-30 | 0.05 |
| 2019-06-30 | 0.05 |
| 2019-03-31 | 0.08 |
| 2018-12-31 | 0.07 |
| 2018-09-30 | -0.05 |
Annual Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2020-09-30 | 0.01 |
| 2019-09-30 | 0.05 |
| 2018-09-30 | -0.05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |